Papers
9
Total Citations
126
H-Index
7
About
Mauro Ragonese is a pioneering urologic surgeon and researcher at the forefront of next-generation robotic surgery. His work centers on evaluating novel surgical platforms—specifically the Hugo™ RAS, Versius, and da Vinci systems—for complex oncologic procedures, with a primary focus on prostate and bladder cancer. Ragonese’s major contributions include the first large-scale series of robot-assisted radical prostatectomy using the Hugo™ RAS platform (132 cases, 23 citations), demonstrating its safety and efficacy. He has also led comparative analyses showing that newer robotic systems can match the gold-standard da Vinci in perioperative and functional outcomes, while systematically assessing surgeon fatigue across minimally invasive approaches. His impact is reflected in over 100 citations across his most-cited works, many published in 2024 alone. Notably, Ragonese introduced the use of trifecta and pentafecta success metrics for radical cystectomy, providing a standardized framework for evaluating surgical quality. His research extends to female sexual function after radical treatment for bladder cancer and novel complications like Hem-o-lok clip migration, underscoring his commitment to comprehensive, patient-centered outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9